Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Cytiva BioProcess R&D AB

Closing information (x1000 NOK)

Closing information 2022/12 2021/12 2020/12
Turnover 16,091,605 Less Arrow 14,419,915 Less Arrow 10,432,045
Financial expenses 10,919 More Arrow 12,874 Less Arrow 12,513
Earnings before taxes 9,366,376 Less Arrow 7,689,012 Less Arrow 3,365,936
EBITDA 15,593,914 Less Arrow 14,115,989 Less Arrow 10,268,596
Total assets 33,495,515 Less Arrow 25,897,047 More Arrow 43,442,752
Current assets 12,459,577 Less Arrow 240,634 More Arrow 8,992,017
Current liabilities 21,641,178 Less Arrow 13,111,310 Less Arrow 910,320
Equity capital 10,910,163 Less Arrow 10,401,205 More Arrow 39,281,989
- share capital 95 More Arrow 98 More Arrow 105
Employees (average) 0 Equal arrow 0 Equal arrow 0

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 32.6% More Arrow 40.2% More Arrow 90.4%
Turnover per employee
Profit as a percentage of turnover 58.2% Less Arrow 53.3% Less Arrow 32.3%
Return on assets (ROA) 28.0% More Arrow 29.7% Less Arrow 7.8%
Current ratio 57.6% Less Arrow 1.8% More Arrow 987.8%
Return on equity (ROE) 85.9% Less Arrow 73.9% Less Arrow 8.6%
Change turnover 2,105,069 More Arrow 4,708,625 Less Arrow 3,318,681
Change turnover % 15% More Arrow 48% Less Arrow 47%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees %

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.